1. FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020 Subject(s): Government RegulationOpioid-Related Disorders -- economicsRisk Evaluation and Mitigation -- legislation & jurisprudenceUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
